Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.92 USD | +0.22% | +0.79% | +24.46% |
12/04 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
08/04 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Sales 2024 * | 4.4B 367B | Sales 2025 * | 4.66B 388B | Capitalization | 10.12B 844B |
---|---|---|---|---|---|
Net income 2024 * | -816M -68.04B | Net income 2025 * | 78M 6.5B | EV / Sales 2024 * | 3.38 x |
Net Debt 2024 * | 4.74B 395B | Net Debt 2025 * | 4.4B 367B | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
-12.5
x | P/E ratio 2025 * |
128
x | Employees | 17,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.1% |
Latest transcript on Catalent, Inc.
1 day | +0.22% | ||
1 week | +0.79% | ||
Current month | -0.94% | ||
1 month | -0.60% | ||
3 months | +7.06% | ||
6 months | +42.40% | ||
Current year | +24.46% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 01/10/01 | |
Matti Masanovich
DFI | Director of Finance/CFO | 52 | 05/23/05 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | 01/14/01 |
John Greisch
CHM | Chairman | 68 | 16/18/16 |
J. Carroll
BRD | Director/Board Member | 74 | 28/15/28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 2 M€ | -.--% | ||
1.21% | 8 M€ | +2.44% | ||
0.83% | 2 M€ | +6.77% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 55.92 | +0.22% | 2,846,393 |
25/24/25 | 55.8 | -0.27% | 1,903,179 |
24/24/24 | 55.95 | -0.14% | 2,031,654 |
23/24/23 | 56.03 | -0.04% | 1,575,946 |
22/24/22 | 56.05 | +1.03% | 1,812,494 |
Delayed Quote Nyse, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.46% | 10.12B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CTLT Stock